develop from precursors found in the dermis. Epidermal LCs are absent in transforming growth factor (TGF) ␤ 1-defi cient mice. It is not clear whether TGF ␤ 1 acts directly on LC precursors to promote maturation or whether it acts on accessory cells, which in turn affect LC precursors. In addition, the physiologic source of TGF ␤ 1 is uncertain because BM chimera experiments showed that neither hematopoietic nor nonhematopoietic-derived TGF ␤ 1 is required for LC development. To address these issues, we created mice transgenic for a bacterial artifi cial chromosome (BAC) containing the gene for human Langerin into which Cre recombinase had been inserted by homologous recombination (Langerin-Cre). These mice express Cre selectively in LCs, and they were bred to fl oxed TGF ␤ RII and TGF ␤ 1 mice, thereby generating mice with LCs that either cannot respond to or generate TGF ␤ 1, respectively. Langerin-Cre TGF ␤ RII mice had substantially reduced numbers of epidermal LCs, demonstrating that TGF ␤ 1 acts directly on LCs in vivo. Interestingly, Langerin-Cre TGF ␤ 1 mice also had very few LCs both in the steady state and after BM transplantation. Thus, TGF ␤ 1 derived from LCs acts directly on LCs through an autocrine/paracrine loop, and it is required for LC development and/or survival.
Langerhans cells (LCs) are a long-lived subset of tissue DCs that reside in the epidermis ( 1 ) . LCs acquire skin antigens, and then migrate to skin-draining LNs in both infl ammatory and steady-state conditions ( 2, 3 ) . LCs are derived from colony-stimulating factor-1 (CSF1) -dependent precursors that originate in the BM and migrate to the dermis before becoming fully differentiated and populating the epidermis ( 4, 5 ) . LC development is aff ected by TGF ␤ 1. BM cells cultured in granulocyte/macrophage CSF and TGF ␤ 1 generate LC-like cells, and LCs are absent from TGF ␤ 1 Ϫ / Ϫ mice ( 6 -8 ) .
In vivo, TGF ␤ 1 is secreted by leukocytes and nonhematopoietic cells, including keratinocytes, and has a pleiotropic role in the immune system ( 9 ) . There are three isoforms of TGF ␤ , but TGF ␤ 1 is the dominant isoform within the immune system. TGF ␤ 1 binds to the TGF ␤ receptor II (TGF ␤ RII) and ALK5 to activate Smad 2, 3, and 4.
Although it is clear that LC development requires TGF ␤ 1, the identity of the cell types responsible for secreting TGF ␤ 1, and whether TGF ␤ 1 acts directly on LCs or via an intermediary cell type, is unresolved. In BM chimeric experiments, TGF ␤ 1 ϩ/ Ϫ severe combined immunodefi cient BM cells transferred into irradiated TGF ␤ 1 Ϫ / Ϫ severe combined immunodefi cient mice are able to produce LCs ( 10 ) . Thus, TGF ␤ 1 derived from nonhematopoietic cells in the skin, such as keratinocytes, is not required, and secretion by a cell of hematopoietic origin is suffi cient for LC development. However, BM cells from TGF ␤ 1 Ϫ / Ϫ mice were also able to generate donor-derived LCs when introduced into irradiated WT recipients, suggesting that nonhematopoietic sources of TGF ␤ 1 are suffi cient to promote LC development ( 11 ) . Interestingly, intradermal, but not intravenous, introduction of TGF ␤ 1 into TGF ␤ 1 Ϫ / Ϫ mice led to LC development, which suggests that TGF ␤ 1 acts on LC precursors within the skin ( 10 ) . Thus, neither hematopoietic nor skin-derived Cre transgene appears to be limited to epidermal LCs and to LCs that have migrated to the skin-draining LN, which is consistent with our prior experience using this BAC ( 12 ) . It is important to note that endogenous mouse Langerin is expressed by several populations of CD8 ␣ ϩ DCs that are present throughout the secondary lymphoid tissue. We and others have shown that these cells are not derived from the epidermis ( 12, 18, 19 ) . These Langerin ϩ , CD8 ϩ DCs were present in Langerin-Cre mice in many tissues ( Fig. 2 B ) . Although we are not sure why expression of Cre under the control of the human Langerin BAC locus is limited to epidermal LCs and not other mouse Langerin-expressing cells, it is clear that these other Langerin-positive cells do not express the transgene and will not confound the analysis of subsequent experiments. TGF ␤ 1 was required for LC development in these models, which leaves the source of TGF ␤ 1 that drives LC development unresolved.
To more defi nitively defi ne the mechanisms by which TGF ␤ promotes LC development in vivo, we developed two lines of mice that have a LC-specifi c deletion of either the gene for TGF ␤ 1 or TGF ␤ RII, thereby generating mice with LC precursors that cannot secrete or respond to the cytokine, respectively.
RESULTS AND DISCUSSION Generation and validation of Langerin-Cre mice
To generate a mouse with selective expression of Cre recombinase in LCs, we used a genomic bacterial artifi cial chromosome (BAC) transgenic system similar to one we recently developed to express diphtheria toxin in LCs ( 12 ) . The human genomic BAC RP11-504o1 contains the gene for Langerin, which is expressed by fully developed LCs ( 13, 14 ) . Transgenic mice made with this BAC express Langerin specifi cally in epidermal LCs ( 12 ) . The gene for a mammalian codonoptimized version of Cre was inserted into the BAC DNA just after the start ATG codon in exon I of Langerin using homologous recombination (Fig. S1 A, available at http:// www.jem.org/cgi/content/full/jem.20071401/DC1) ( 15, 16 ) . The correct insertion of Cre into exon I was confi rmed by PCR (not depicted) and by restriction digest (Fig. S2) . A 72-kb NotI fragment of this modifi ed BAC was used to generate a single Langerin-Cre transgenic founder from 20 live births. Langerin-Cre mice are indistinguishable from littermate controls and have normal numbers of LCs, dermal DCs, other DC subtypes, and B and T cells in their spleen and LN (unpublished data).
To validate that Cre expression was restricted to LCs, Langerin-Cre mice were bred to Rosa26-enhanced GFP (EGFP) mice that have EGFP inserted into a ubiquitously expressed genomic locus behind fl oxed " stop " sequences ( 17 ) . Cre activity deletes the stop sequences, thereby allowing EGFP expression only in those cells that express the Cre transgene. To quantify the number of LCs expressing the Cre transgene, we examined epidermal single-cell suspensions by fl ow cytometry. As expected, all epidermal MHC-II ϩ , CD11c ϩ LCs from Langerin-Cre ϩ Rosa26-EGFP f/f mice showed expression of EGFP ( Fig. 1 A , left, thick line) . In contrast, EGFP was expressed only in a small subset of MHC-II ϩ cells in dermal single-cell suspensions ( Fig. 1 A , right) . These EGFP ϩ cells are likely either LC precursors that reside in the dermis or epidermal LCs in the process of migrating though the dermis to regional LNs. EGFP ϩ cells were not observed in littermate control mice.
EGFP could also be identifi ed on CD11c int cells within the cutaneous LNs ( Fig. 1 B ) . These cells were CD8 ␣ Ϫ and DEC-205 bright , which is consistent with their identity as LCs that have migrated to the skin-draining LN ( Fig. 1 C ) . Importantly, we did not observe EGFP expression in any other cell present in the LN. There were no detectable EGFP ϩ cells in spleen, mesenteric LN, and thymus ( Fig. 2 A ) . Thus, expression of the To further investigate this fi nding, we examined epidermal sheets by immunofl uorescence for the presence of LCs. In young, 22-d-old mice, MHC-II ϩ LCs were rare, and they appeared as individual cells ( Fig. 3 C ) . In mice at 60 d of age, single cells could no longer be identifi ed. Instead, there were clusters of LCs scattered throughout the epidermis that, by day 89, were signifi cantly larger. To confi rm that these cells were, in fact, LCs, and not another cell type that colonized the epidermal niche in the absence of LCs, epidermal sheets were stained with both anti -MHC-II and anti-Langerin (Fig. S2) . All of the MHC-II ϩ cells in both young and old mice also expressed Langerin, thereby demonstrating that they are LCs. The fact that escaped LCs in Langerin-Cre TGF ␤ RII f/f mice are found as single cells in young mice, but appear in increasingly large clusters in older mice, supports the notion that fully diff erentiated LCs derive from locally proliferating precursors in the steady state ( 4, 21, 22 ) .
LCs require autocrine/paracrine TGF ␤ 1 for development There are many potential sources of TGF ␤ 1 available to the developing LC in the skin, including keratinocytes, fi broblasts, resident T cells, and LCs themselves ( 9, 23 ) . To examine whether autocrine secretion of TGF ␤ 1 participates in LC development, we bred Langerin-Cre mice to mice in which LCs require the direct action of TGF ␤ It is well established that TGF ␤ 1 is required for LC development ( 6 -8 ) . Given that nearly all cells express receptors for TGF ␤ 1, it is less clear whether LCs have a direct requirement for TGF ␤ 1 or if TGF ␤ 1 acts via another cell type, which then assists with LC development. To examine this, Langerin-Cre mice were bred to mice carrying a TGF ␤ RII-fl oxed allele ( 20 ) . Langerin-Cre TGF ␤ RII f/f mice are predicted to have LC precursors that are unable to respond to TGF ␤ 1. LangerinCre TGF ␤ RII f/f mice appeared grossly normal and had normal numbers of lymphocytes and DCs in their spleen and LN (unpublished data). In single-cell epidermal suspensions from these mice, there was a decreased number of MHC-II ϩ cells compared with littermate Langerin-Cre TGF ␤ II f/f controls ( Fig. 3 A , top) . Although the number of LCs was substantially reduced, a variable number of LCs were present in the epidermis of these mice. We hypothesized that residual LCs in Langerin-Cre TGF ␤ RII f/f mice were cells that had not deleted both TGF ␤ RII alleles. Indeed, all epidermal LCs pre sent in Langerin-Cre TGF ␤ RII f/f mice expressed TGF ␤ RII at levels similar to littermate controls ( Fig. 3 A , bottom) . Thus, those LC precursors that continued to express TGF ␤ RII, presumably because of failure to excise both fl oxed loci, retained TGF ␤ sensitivity and developed into LCs, whereas those in which both alleles of TGF ␤ RII were excised did not. Thus, we conclude that LCs require the direct action of TGF ␤ 1 for their terminal development and/or survival.
Although the percentage of " escaped " LCs present in the epidermis of Langerin-Cre TGF ␤ RII f/f mice was always smaller than littermate controls, it was quite variable, ranging the gene for TGF ␤ 1 was fl oxed, thereby generating mice with a LC-selective ablation of TGF ␤ 1 ( 24 ) . These Langerin-Cre TGF ␤ 1 f/f mice appeared grossly normal, did not have overt histologic evidence of autoimmune disease in the skin, and had normal numbers of lymphocytes and DCs in their spleen and LN (unpublished data). We consistently observed a large decrease in the number of LCs in Langerin-Cre TGF ␤ 1 f/f mice. LCs comprised 0.02 -0.1% of epidermal cells in Langerin-Cre TGF ␤ 1 f/f mice compared with 0.42 -1.17% in littermate controls ( Fig. 4, A and B ) . Immunofl uorescence of whole-mounted ear epidermis confi rmed this result. In Langerin-Cre TGF ␤ 1 f/f mice, LCs were absent from the vast majority of the ear, but could be observed focally as MHC-II ϩ , Langerin ϩ cells in a few areas ( Fig. 4 C ) . As was seen with the Langerin-Cre TGF ␤ RII f/f mice, escaped LCs were found in clusters that, interestingly, were often located at the edge of the ear.
TGF ␤ 1-fl oxed mice were constructed by insertion of loxP sites 5 Ј of the promoter region of Tgfb1 and 3 Ј of exon 1 in the fi rst intron ( 24 ) . The location of the loxP sites, however, encompasses the fi nal exon of a hypothetical gene, LOC232987 , leading to the abrogation of TGF ␤ 1 and LOC232987 expression. To address the possibility that the absence of LCs was caused by the absence of LOC232987 and not TGF ␤ 1, Langerin-Cre TGF ␤ 1 f/n mice were generated. TGF ␤ n mice have GFP inserted into the fi rst exon of Tgfb1 gene that disrupts TGF ␤ 1 expression, but leaves LOC232987 intact ( 24 ) . LCs in Langerin-Cre TGF ␤ 1 f/n mice will have both alleles of the Tgfb1 gene disrupted, but retain a functional allele of LOC232987. These mice showed a dramatic decrease in the number of epidermal LCs and were indistinguishable from Langerin-Cre TGF ␤ 1 f/f mice, thereby validating that the absence of LCs in Langerin-Cre TGF ␤ 1 f/f mice was caused by the requirement for LC-derived TGF ␤ 1 (unpublished data).
The requirement for LC-derived TGF ␤ 1 in LC development was unexpected, given the observation by Borkowski et al. that donor-derived LCs develop in TGF ␤ 1 − / − → WT BM chimeric mice ( 11 ) . One explanation for the apparent discrepancy between our results and theirs is that LC repopulation of the epidermis after BM transplantation may not be analogous to epidermal population during ontogeny and, in contrast to our results, could occur in the absence of LC-derived TGF ␤ 1. We examined this by creating BM chimeras using LangerinCre TGF ␤ 1 f/f and control littermate Cre − TGF ␤ 1 f/f mice (both CD45.2 ϩ ) as BM donors and WT CD45.1 congenic B6 mice as recipients. Half of the recipients were treated with UVC 1 d after transplant, which eliminates host LCs and is known to enable the development of donor-derived LCs in the epidermis after BM transplantation ( 22 ) . Hematopoietic engraftment in both sets of chimeras was confi rmed by detecting CD45.2 by fl ow cytometry 8 wk after transplant 
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acts directly on LCs and not indirectly via another cell type. This was a nontrivial possibility given the large number of cell types that express receptors for TGF ␤ . In addition, because Langerin, and hence Cre, are thought to be expressed only by mature LCs, our data indicates that LCs must require TGF ␤ 1 after they begin to express Langerin ( 14 ) . Indeed, Langerin mRNA transcripts are detectable in the skin of TGF ␤ 1 Ϫ / Ϫ mice, and local introduction of TGF ␤ 1 can rescue LC development in TGF ␤ 1 Ϫ / Ϫ mice ( 10, 25 ) . Considering these results with our data, we conclude that LC precursors become TGF ␤ 1 dependent only once they are in the skin and begin to express Langerin. TGF ␤ 1 signaling induces the transcription factor Id2 ( 26 ) . The absence of both LCs and splenic CD8 ϩ DCs in Id2 Ϫ / Ϫ mice raised the possibility that both cell types may share a common TGF ␤ 1-dependent precursor ( 26 ) . The requirement for TGF ␤ 1 by LCs only once they are already in the skin, however, suggests that Id2 could be required only after they have become distinct lineages.
Our observation that Langerin-Cre TGF ␤ 1 f/f mice have a greatly reduced number of LCs clearly demonstrates a nonredundant, in vivo requirement for paracrine or autocrine TGF ␤ 1 for the development of mature LCs. Whether TGF ␤ 1 acts transiently to foster LC development and/or is required as a survival factor is unclear. TGF ␤ 1 is produced by epidermal keratinocytes, making it plausible that LC-derived TGF ␤ 1 allows survival until LCs reach the epidermis, at which point keratinocytes could instead provide the necessary TGF ␤ 1. Hematopoietic stem cells (HSCs) were thought to use an autocrine/ paracrine TGF ␤ loop to maintain HSC quiescence ( 27 ) .
(unpublished data). As expected, immunofl uorescence of epidermal whole mounts revealed that UVC-treated recipients of control Cre Ϫ TGF ␤ 1 f/f BM developed normal numbers of CD45.2 ϩ (donor) Langerin ϩ LCs throughout the epidermis ( Fig. 5 A ) . In contrast, UVC-treated recipients of Langerin-Cre TGF ␤ 1 f/f BM had virtually no detectable LCs, and the rare LCs present were of donor origin. Recipients of Langerin-Cre TGF ␤ 1 f/f and control BM that were not irradiated with UVC retained LCs of recipient origin ( Fig. 5 B ) , as expected ( 22 ) . Thus, LC epidermal repopulation after BM transplantation recapitulated the steady state and, in our hands, is dependent on LC-derived TGF ␤ 1.
We have described the generation of Langerin-Cre, BAC-transgenic mice and demonstrated that expression of Cre in these mice is limited to epidermal and skin-derived LCs. By breeding these mice to fl oxed TGF ␤ RII and TGF ␤ 1 mice, we developed mice in which LCs are either insensitive to or unable to produce TGF ␤ 1, respectively. The reduction of LCs in both of these strains of mice demonstrates that LC-derived TGF ␤ 1 directly and nonredundantly promotes LC development during ontogeny and in the steady state. Our BM transplantation experiments further demonstrate a requirement for LC-derived TGF ␤ 1, even during repopulation after UV irradiation.
The general importance of TGF ␤ 1 in LC development was already appreciated based on the absence of LCs in TGF ␤ 1 Ϫ / Ϫ mice and the ability of TGF ␤ 1 to enhance production of LCs in in vitro cultures ( 6 -8 ) . The lack of LCs in Langerin-Cre TGF ␤ RII mice demonstrates that TGF ␤ 1 what would otherwise be a very rare cell to expand. The observation that escaped LCs in Langerin-Cre TGF ␤ RII f/f occur in clusters argues that fully diff erentiated LCs derive from locally proliferating precursors in the steady state ( 4, 21, 22 ) . Moreover, the expanding size of the clusters with age suggests that LCs are proliferating within the epidermis, though proliferation in the dermis and subsequent migration into the epidermis cannot be excluded.
Langerin-Cre TGF ␤ 1 → WT UV-treated chimeras do not develop donor-derived LCs. Thus, LC-derived TGF ␤ 1 is required for LC repopulation after UV treatment, as well as to establish a normal complement of epidermal LCs during ontogeny. The absence of LCs in Langerin-Cre TGF ␤ F/F chimeras was particularly surprising, given the presence of donor-derived LCs in the original TGF ␤ 1 Ϫ / Ϫ → WT experiments by Borkowski et al. ( 11 ) . A potentially important distinction is that in the Borkowski et al. experiments, all hematopoietic cells lacked the gene for TGF ␤ 1, unlike Langerin-Cre TGF ␤ 1 chimeras, in which the defect was limited to LCs. Levels of TGF ␤ 2 are elevated in the skin of TGF1 ␤ Ϫ / Ϫ mice ( 11 ) . It is possible that in the absence of hematopoietically derived TGF ␤ 1, compensatory TGF ␤ 2 or other TGF ␤ family members such as activin, which potentially could promote LC development, were induced, and thus masked the physiologic requirement for LC-derived TGF ␤ 1 ( 10, 11, 28 ).
However, in vivo experiments, using conditionally ablated TGF ␤ RII revealed that the absence of TGF ␤ signaling had no eff ect on HSCs, and the reliance on TGF ␤ in vitro was presumably caused by an indirect eff ect, such as the absence of soluble or environmental factors present in vivo ( 27 ) . This highlights the diffi culty of studying TGF ␤ in vitro and the importance of in vivo experimental systems. We believe this is the fi rst documented hematopoietic cell type that is dependent on TGF ␤ for its development. Recent studies have also revealed an important function for T cell -derived TGF ␤ 1 in regulating T cell function ( 24 ) . Thus, regulation via TGF ␤ autocrine/paracrine loops may be a more common phenomenon than previously realized.
The deletion of the fl oxed loci in TGF ␤ RII f/f mice does not occur in every LC precursor, which allows some to retain sensitivity to TGF ␤ 1 and repopulate the empty epidermal niche. One explanation for this would be that rare LC precursors in Langerin-Cre mice express insuffi cient levels of Cre to delete both alleles of the fl oxed locus. This could explain why all LCs express EGFP in Langerin-Cre Rosa-EGFP mice, which only require deletion of a single fl oxed allele. Other fl oxed genes that are not required for LC survival, such as I-A ␤ , have both alleles effi ciently excised by all LCs (unpublished data). Thus, it is more likely that the strong selective advantage of retaining sensitivity to TGF ␤ 1 allows 
Flow cytometry. Single-cell suspensions of epidermis, LN, thymus, and spleen were obtained and stained as previously described ( 12 ) . Live/dead discrimination was obtained using propidium iodide (Invitrogen) or ethidium monoazide (Invitrogen). Samples were analyzed on a FACSCalibur or LSR-II fl ow cytometer (BD Biosciences).
Immunofl uoresence. Epidermal sheets were prepared by affi xing ears to slides using double-sided adhesive (3M), followed by incubation in 21 mM EDTA in PBS for 2 h at 37 ° and physical removal of the dermis, as previously described ( 12 ) .
Generation of chimeric mice. BM cells were obtained from either Langerin-Cre TGF ␤ f/f or Cre Ϫ littermate control mice. Cells were incubated in ACK buff er for erythroid cell lysis and resuspended in injection buff er (1 ϫ PBS, 10 mM Hepes, 2.5% acid citrate dextrose anticoagulant, and 0.5% penicillin/streptomycin). Recipient B6 CD45.1 mice received 775 cGy from a cesium irradiator and were reconstituted with 10 7 cells/mouse. 1 d after transplantation, one cohort of mice was exposed to 450 mJ UVC light. Mice were rested for at least 8 wk before experimentation.
Statistics.
Statistical comparisons between groups were made using a standard two-tailed Student ' s t test. Linear regression was used to evaluate for correlation in Fig. 3 B .
Online supplemental material. Fig. S1 shows the generation of Langerin-Cre BAC. It is also important to note that Borkowski et al. observed donor-derived LCs in control and TGF ␤ 1 Ϫ / Ϫ chimeras in the absence of UV treatment. Others have clearly shown that LCs are radio resistant, and repopulation from donor BM requires ablation of host LCs, such as that which occurs after UV treatment or cutaneous graft versus host disease ( 22, 29 ) , a fi nding that we have confi rmed. Although no obvious evidence of cutaneous autoimmunity was observed in the Borkowski study (Udey, M., personal communication), minor histocompatability diff erences between a partially backcrossed donor and an inbred recipient could have accounted for the presence of donor LCs in the absence of UV treatment and allowed LC development in the absence of LCderived TGF ␤ 1.
LC-derived TGF ␤ 1 could also participate in other aspects of LC biology, such as maintaining an immature LC phenotype, determining whether precursors become LCs or other DC subtypes (e.g., dermal DCs), and/or regulating cutaneous immune responses. Because LCs lacking TGF ␤ 1 fail to develop, it is much more challenging to examine the possible roles of TGF ␤ 1 in subsequent phases of the LC lifecycle. We are in the process of generating mice that will express an inducible form of Cre in LCs, which should permit us to investigate the ongoing roles of TGF ␤ 1 in LC biology beyond the required initial autocrine/paracrine loop we have defi ned in this work.
MATERIALS AND METHODS
BAC and transgenic mice. The human BAC clone RP11-504o1 was obtained from Invitrogen. The sequence for Cre recombinase, which had optimized with mammalian codon usage (iCre; a gift from R. Sprengel, Max-Planck Institute for Medical Research, Heidelberg, Germany; reference [ 15 ] ), was inserted immediately after the start ATG in exon I of Langerin using homologous recombination in Escherichia coli , as previously described ( 12 ) . Recombined BAC clones were confi rmed by PCR and by XhoI (New England Biolabs) restriction digest. BAC DNA for microinjection was obtained as previously described ( 12 ) and injected at 1 -2 ng/ l by the Yale Genomics Services Transgenic Mouse Service into the pronuclei of (C57BL/6j x SJL/j) F2 embryos. Langerin-Cre founders were identifi ed by PCR for RP11-50401, as previously described ( 12 ) .
Mice. Langerin-Cre mice were bred onto the following strains: Rosa26. EFGP (The Jackson Laboratory), floxed TGF ␤ RII (a gift from H. Moses, Vanderbilt University School of Medicine, Nashville, TN; reference [ 20 ] ), fl oxed TGF ␤ 1 ( 24 ) , and TGF ␤ 1-GFP (unpublished data). C57BL/6 CD45.1 mice were obtained from The Jackson Laboratory. All experiments were performed with age-and sex-matched mice. Mice were housed in microisolator cages and fed autoclaved food and acidifi ed water. The Yale Institutional Animal Care and Use Committee approved all mouse protocols.
Antibodies. Antibodies to the following targets were used: muLangerin (929F3; provided by S. Saeland, Dendritics, Dardilly, France), CD11c (N418-FITC and APC; eBioscience), I-A/E (M5/144.15.2-FITC and biotin; BioLegend), CD11b (M1/70-PE; BD PharMingen), CD45.1 (A20-FITC; BD PharMingen), CD45.2 (104-FITC; BD PharMingen), and CD8 ␣ (Ly-2-PE; BD PharMingen). NLDC-145 (anti-DEC-205) and 24G2 (antiFcR ␥ ) were purifi ed from hybridoma supernatants, as previously described ( 30 ) . Conjugation to biotin or Alexa Fluor 647 was performed according to the manufacturer ' s directions (Invitrogen).
